Comparing the effects of palmitate, insulin, and palmitate‐insulin co‐treatment on myotube metabolism and insulin resistance. Issue 6 (12th August 2021)

• Record Type: Journal Article
• Authors: Rivera, Madison E.; Vaughan, Roger A.
• Is Part Of: Lipids. Volume 56:Issue 6(2021)
• Page Start: 563
• Page End: 578
• Publication Date: 2021-08-12
• Subjects: BCAA -- diabetes -- insulin resistance -- mitochondrial biogenesis -- PGC‐1α; Lipids -- Periodicals; Lipids -- Periodicals; Lipiden; Lipides -- Périodiques; 547.77
• DOI: 10.1002/lipd.12315
• Languages: English
• ISSNs: 0024-4201

Abstract

Abstract: Previous studies have shown various metabolic stressors such as saturated fatty acids (SFA) and excess insulin promote insulin resistance in metabolically meaningful cell types (such as skeletal muscle). Additionally, these stressors have been linked with suppressed mitochondrial metabolism, which is also a common characteristic of skeletal muscle of diabetics. This study characterized the individual and combined effects of excess lipid and excess insulin on myotube metabolism and related metabolic gene and protein expression. C2C12 myotubes were treated with either 500 μM palmitate (PAM), 100 nM insulin (IR), or both (PAM‐IR). qRT‐PCR and western blot were used to measure metabolic gene and protein expression, respectively. Oxygen consumption was used to measure mitochondrial metabolism. Glycolytic metabolism and insulin‐mediated glucose uptake were measured via extracellular acidification rate. Cellular lipid and mitochondrial content were measured using Nile Red and NAO staining, respectively. IR and PAM‐IR treatments led to reductions in p‐Akt expression. IR treatment reduced insulin mediated glucose metabolism while PAM and PAM‐IR treatment showed increases with concurrent reductions in mitochondrial metabolism. All three treatments showed suppression in mitochondrial metabolism. PAM and PAM‐IR also showed increases in glycolytic metabolism. While PAM and PAM‐IR significantly increased lipid content, expression of inflammatory and lipogenic proteins were unaltered. Lastly, PAM‐IR reduced BCAT2 protein expression, a regulator of BCAA metabolism. Both stressors independently reduced insulin signaling, mitochondrial function, and cell metabolism, however, only PAM‐IR co‐treatment significantly reduced the expression of regulators of metabolism not seen with individual stressors, suggesting an additive effect of stressors on metabolic programming.